Our Approach
How the generator
is built
Reference-conditioned autoregressive generation plus condition injection. A clinical caller is in development. It is not for sale.
Generator
Reference-conditioned architecture
The product you can buy is labelled FASTQ from a reference-conditioned generator, not a clinical prenatal test.
Research on low fetal fraction remains open. We do not sell a 1–2% FF clinical test.
Key technical innovations include:
- Reference-conditioned generation so injected karyotypes survive alignment
- Controllable fetal fraction, karyotype, and fragment depth
- Paired-end FASTQ plus metadata for caller and pipeline regression
Data Generation
Synthetic cfDNA Technology
Our synthetic data generation uses a reference-conditioned autoregressive model (132.5M parameters) trained on real cfDNA fragments. The model generates sequences conditioned on the GRCh38 reference genome so injected karyotypes can survive alignment.
The generation process provides precise control over:
- Fetal fraction: 1-25% with continuous control
- Karyotype: T21, T18, T13, 45,X, 47,XXX, the rare autosomal trisomies, and the autosomal microdeletions and duplications generate the expected signal today. T21 has been checked end to end on sequenced output; the others pass our internal tests only.
- Fragment characteristics: size distribution, GC content, coverage patterns
- Sample depth: 4M to 32M fragments on the public pack path
This technology supplies labelled FASTQ for NIPT algorithm development. A clinical caller is in development and is not for sale.
Validation
Validation framework
This is the one validation result we claim.
Train Synthetic, Test Real
A classifier trained only on our synthetic data reached AUC 0.87 for T21 on one published dataset (Lun et al. 2014: 26 unique samples, 6 T21 and 20 euploid; p = 0.002).
AUC 0.87 for T21Results
Synthetic Data Validation Results
Research
Publications
Research publications are forthcoming in 2026. We are preparing manuscripts detailing generator architecture and synthetic-data experiments.
Preprint expected H2 2026.
Open Science
Commitment to Open Source
We believe in advancing prenatal genomics through open collaboration. Synthetic cfDNA generation is available now for research use from the dashboard, so labs can reproduce experiments without sharing patient data.
View our GitHub